Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Masako Kuno
Observed names:
Kuno, Masako,
Masako KUNO
Institution:
Takeda (Japan)
Observed institutions:
Astellas Pharma (Japan),
Takeda (Japan),
The University of Osaka
OpenAlex ID:
A5111976902
Discovery of 7-Oxo-2,4,5,7-tetrahydro-6 H -pyrazolo[3,4- c ]pyridine Derivatives as Potent, Orally Available, and Brain-Penetrating Receptor Interacting Protein 1 (RIP1) Kinase Inhibitors: Analysis of Structure–Kinetic Relationships
2018
·
Masato Yoshikawa
, Morihisa Saitoh
, et al.
·
Journal of Medicinal Chemistry
·
131
A novel JAK inhibitor, peficitinib, demonstrates potent efficacy in a rat adjuvant-induced arthritis model
2016
·
Misato Ito
, Shunji Yamazaki
, et al.
·
Journal of Pharmacological Sciences
·
99
PDF
In Vitroandin VivoActivities of T-705 and Oseltamivir against Influenza Virus
2003
·
Kazumi Takahashi
, Yousuke Furuta
, et al.
·
Antiviral chemistry & chemotherapy
·
97
PDF
A Highly Potent Non-Nucleoside Adenosine Deaminase Inhibitor: Efficient Drug Discovery by Intentional Lead Hybridization
2003
·
Tadashi Terasaka
, Takayoshi Kinoshita
, et al.
·
Journal of the American Chemical Society
·
58
Strain difference in the induction of T-cell activation-associated, interferon gamma-dependent hepatic injury in mice
1998
·
Hidekazu Mizuhara
, Masako Kuno
, et al.
·
Hepatology
·
55
PDF
CETSA quantitatively verifies in vivo target engagement of novel RIPK1 inhibitors in various biospecimens
2017
·
Tsuyoshi Ishii
, Takuro Okai
, et al.
·
Scientific Reports
·
53
PDF
Structural Basis of Compound Recognition by Adenosine Deaminase
2005
·
Takayoshi Kinoshita
, Isao Nakanishi
, et al.
·
Biochemistry
·
49
Anti-inflammatory activity of non-nucleoside adenosine deaminase inhibitor FR234938
2006
·
Masako Kuno
, Nobuo Seki
, et al.
·
European Journal of Pharmacology
·
47
Structure-Based Design, Synthesis, and Structure−Activity Relationship Studies of Novel Non-nucleoside Adenosine Deaminase Inhibitors
2004
·
Tadashi Terasaka
, Takayoshi Kinoshita
, et al.
·
Journal of Medicinal Chemistry
·
41
Structure-Based Design and Synthesis of 3-Amino-1,5-dihydro-4H-pyrazolopyridin-4-one Derivatives as Tyrosine Kinase 2 Inhibitors
2015
·
Takatoshi Yogo
, Hiroyuki Nagamiya
, et al.
·
Journal of Medicinal Chemistry
·
31
Pharmacological profile of FK881(ASP6537), a novel potent and selective cyclooxygenase-1 inhibitor
2011
·
Junko Imanishi
, Yoshiaki Morita
, et al.
·
Biochemical Pharmacology
·
26
Structure-Based Design and Synthesis of Non-Nucleoside, Potent, and Orally Bioavailable Adenosine Deaminase Inhibitors
2004
·
Tadashi Terasaka
, Hiroyuki Okumura
, et al.
·
Journal of Medicinal Chemistry
·
25
Discovery and pharmacological characterization of a new class of prolyl-tRNA synthetase inhibitor for anti-fibrosis therapy
2017
·
Akira Shibata
, Masako Kuno
, et al.
·
PLoS ONE
·
24
PDF
Structure-Based de novo design of non-nucleoside adenosine deaminase inhibitors
2003
·
Tadashi Terasaka
, Isao Nakanishi
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
21
Rational Design of Non-Nucleoside, Potent, and Orally Bioavailable Adenosine Deaminase Inhibitors: Predicting Enzyme Conformational Change and Metabolism
2005
·
Tadashi Terasaka
, Kiyoshi Tsuji
, et al.
·
Journal of Medicinal Chemistry
·
20
Design, synthesis, and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitors – Part 3
2016
·
Tomoya Yukawa
, Yoshihisa Nakada
, et al.
·
Bioorganic & Medicinal Chemistry
·
14
Dual CCK-A and CCK-B Receptor Antagonists (II). Preparation and Structure Activity Relationships of 5-Alkyl-9-methyl-1,4-benzodiazepines and Discovery of FR208419.
2000
·
Seiichiro TABUCHI
, Harunobu ITO
, et al.
·
Chemical and Pharmaceutical Bulletin
·
10
PDF
Discovery of a Novel Series of Potent, Selective, Orally Available, and Brain-Penetrable C1s Inhibitors for Modulation of the Complement Pathway
2023
·
Zenichi Ikeda
, Taku Kamei
, et al.
·
Journal of Medicinal Chemistry
·
9
PDF
Design, synthesis and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitor
2015
·
Ikuo Fujimori
, Tomoya Yukawa
, et al.
·
Bioorganic & Medicinal Chemistry
·
9
Role of vasopressin V1Areceptor in the urethral closure reflex in rats
2011
·
Hiroyuki Ueno
, Masako Kuno
, et al.
·
American Journal of Physiology-Renal Physiology
·
8
A Highly Potent Non-Nucleoside Adenosine Deaminase Inhibitor: Efficient Drug Discovery by Intentional Lead Hybridization [J. Am. Chem. Soc. 2004, 126, 34−35].
2004
·
Tadashi Terasaka
, Takayoshi Kinoshita
, et al.
·
Journal of the American Chemical Society
·
8
PDF
Increasing Effects of Selective 5-Hydroxytryptamine Type 2C Receptor Stimulation on Evoked Momentary Urethral Closure in Female Rats and Humans
2021
·
Izumi Kamo
, Hiroshi Nagata
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
7
PDF
Effect of FK480, a CCK-A Receptor Antagonist, on Spontaneously Developed Chronic Pancreatitis in WBN/ob Rats
1998
·
Harunobu Ito
, Hajime Sogabe
, et al.
·
Pancreas
·
6
Design, synthesis, and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitors—Part 2
2016
·
Tomoya Yukawa
, Ikuo Fujimori
, et al.
·
Bioorganic & Medicinal Chemistry
·
5
Dual CCK-A and -B receptor antagonists (I) C9-methyl-1,4-benzodiazepines
1997
·
Seiichiro Tabuchi
, Harunobu Ito
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
5
Show more works
View as search
Works count:
36
Citation count:
865
H-index:
15
I10-index:
17
Year
Topic
Type